Remove 2015 Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

Cancer vaccines: providing the edge in oncology

pharmaphorum

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.

Vaccines 134
article thumbnail

A Pharmacist’s Path Towards Developing Medical Strategy for Field-Based Teams

Pharmacy Is Right For Me

Dr. Brown is the National Field Director for Janssen Infectious Diseases & Vaccines. I have been in the pharmaceutical industry since 2007 and have been in various roles involving medical affairs and research and development. From 2015 through Jan 2018, I served as the U.S. What makes your career path unique?

Vaccines 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Innovation across the healthcare system is needed to realise the value of medicines

pharmaphorum

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world. About the author.

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

Ageing will only compound the challenge: high income country populations are already old, but between 2015 and 2050, the proportion of the world’s population aged over 60 will nearly double, from 12% to 22%, and, by 2050, 80% of older people will be living in low- and middle-income countries.

FDA 98
article thumbnail

Nanoparticles: Emerging Stars for Pharmaceutical Industry

Roots Analysis

Hence, many pharmaceutical companies outsource manufacturing of nanoparticles to third party organizations, called as contract manufacturers. Variety of services provided by contract manufacturers are as follows: Nanoparticles: Emerging Stars for Pharmaceutical Industry.

article thumbnail

Beating the Big C

Pharmaceutical Technology

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. Analysts predict Pfizer’s revenue stream would be slashed by 25% by 2015 if the company did not branch out into other areas.

article thumbnail

Preparing for a post-pandemic world

pharmaphorum

In his 2015 TED talk, Bill Gates surmised that a highly infectious virus, rather than a war, was our greatest risk of global catastrophe. The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development. COVID-19 hit us hard. And there were warnings.